Clinical Trial

Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, continuing, Phase II expansion trial to evaluate the safety, efficacy, and immunogenicity of two doses of TQH2722 in the long-term treatment of severe chronic sinusitis with or without nasal polyps.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-14
notable Primary completion moved earlier: 2026-06 -> 2025-12-19 2026-08-14
minor Completion moved earlier: 2026-06 -> 2025-12-19 2026-08-14
Trial Details
NCT Number NCT06439381
Lead Sponsor Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions Chronic Rhinosinusitis
Enrollment 119 participants
Start Date 2024-07-16
Primary Completion 2025-12-19 (estimated)
Study Completion 2025-12-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-13